Utilizza questo identificativo per citare o creare un link a questo documento: http://elea.unisa.it/xmlui/handle/10556/2213
Titolo: Synthesis of calixarene derivatives active towards proteic targets involved in tumor pathologies
Autore: Tommasone, Stefano
Guerra, Gaetano
Gaeta, Carmine
Parole chiave: Calixareni;Riconoscimento biomolecolare
Data: 15-mar-2016
Editore: Universita degli studi di Salerno
Abstract: Over the last 30 years a growing interest has been direct toward the biomolecular recognition of calixarene derivatives and more in particular to the interaction with druggable target(s).1,2 The aim of this PhD thesis was the synthesis and the study of calixarenes that were able to interact with biomolecules involved in tumor pathologies. One of the main topic of this work was the synthesis of calix[4]arene conjugates bearing pyrenylisoxazolidine moieties at the exo rim which could act as potential DNA intercalators. The in vitro cytotoxic activity against different human tumor cell lines was also tested. Moreover, the biomolecular recognition abilities of designed calixarenes was studied through a chemical proteomics approach. As calix[n]arene scaffolds are particularly suitable for the synthesis of multivalent ligands,3 the attention was also focused on the synthesis of multivalent iminosugar-calix[8]arene conjugates for the inhibition of glycosidases. The synthesis, characterization and all the biomolecular recognition studies were herein described. [edited by author]
Descrizione: 2014 - 2015
URI: http://hdl.handle.net/10556/2213
È visualizzato nelle collezioni:Chimica

File in questo documento:
File Descrizione DimensioniFormato 
tesi S. Tommasone.pdftesi di dottorato6,84 MBAdobe PDFVisualizza/apri
abstract in italiano S. Tommasone.pdfabstract in italiano a cura dell'autore422,05 kBAdobe PDFVisualizza/apri
abstract in inglese S. Tommasone.pdfabstract in inglese a cura dell'autore378,21 kBAdobe PDFVisualizza/apri


Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.